Foros Electrónica
Alguien dijo ...
El número es el que rige las formas y las ideas, y la causa de los dioses y los demonios

Pitágoras(siglo VI A.C.)
Sitios recomendados
Advance Nanotech Continues to Grow Senior Management Team

New York City — Advance Nanotech, Inc. today announced the appointment of Dr. Fred Allen to the position of Senior Vice President, Materials. Dr. Allen will be responsible for managing all of the firm's partnerships and investments related to materials sciences. He will report directly to Advance Nanotech CEO Magnus Gittins.

"Dr. Allen possesses a strong background in research and development in nanotechnology and materials science. His experiences in coordinating research and development initiatives with sales, marketing, IP management, safety, manufacturing and external regulator efforts will prove invaluable in his new role at Advance Nanotech," said Gittins. "We are very pleased to have him join the Advance team."

Prior to joining Advance Nanotech, Dr. Allen held a management position in R&D at Engelhard Corporation where he led the technology assessment function and nanotechnology program. Dr. Allen also supported Engelhard's Ventures Group, where he played a key role in evaluating commercial opportunities for the firm. He is a co-founder of the Greater Garden State Nanotechnology Alliance. Dr. Allen's materials expertise spans minerals, ceramics and metals and involves crystal structure determination using X-ray and electron diffraction, optical and electron microscopy, image analysis, electron microprobe analysis, surface chemical analysis, and thermal analysis. Dr. Allen holds degrees from Harvard University and The State University of New York at Stony Brook. He is responsible for 10 patent filings and 30 publications and presentations throughout his career.

Advance Nanotech is currently funding 18 portfolio companies in the electronics, biopharma, and materials industries. The firm provides services ranging from funding, to human capital and research equipment essential to ensuring that the most promising companies can accelerate the path to rapid commercialization. In this way, investor exposure to any particular technology is mitigated with Advance Nanotech retaining the option to increase investment in those technologies that successfully mature. Dr. Allen will be responsible for overseeing the firm's materials-focused investments.

Miércoles, 27 Julio, 2005 - 09:26
powered by phppowered by MySQLPOWERED BY APACHEPOWERED BY CentOS© 2004 F.J.M.Información LegalPrensa
Esta web utiliza cookies, puedes ver nuestra política de cookies, aquí Si continuas navegando estás aceptándola
Política de cookies +